Scientific talks

TRUPATH is a BRET-based platform that enables to monitor discrete GPCR-G protein coupling and can facilitate the discovery of drugs biased towards desired G protein effectors.

In this talk we highlight how advanced detection technologies such as NanoBRET and TR-FRET can be used in high-throughput drug screening.

Shalini Markandan, Forest Research Institute of Malaysia, discusses misconceptions about ORAC, provides a better way to interpret data, highlights challenges for ORAC beginners, and shows how BMG LABTECH microplate readers can help.

In this talk, Daniel Thomas, Head of Discovery Biology at Arctoris, describes the acceleration of onboarding and validation of three critical assays targeted on SARS-CoV-2 drug discovery

Ahlam Ali from Queen’s University Belfast, UK shows results from a screen for antiviral and anti-inflammatory activity against SARS-CoV-2 using a drug repurposing approach.

This talk answers the question whether redox sensitive probes can be used to monitor redox enzyme activity.

In this tutorial, Jaime Padrós of BioAuxilium Research introduces a new line of ready-to-use cell signaling assay kits based on their enhanced proprietary TR-FRET platform.

In this webinar, Dr. Alfredo Castello (University of Glasgow) will describe a recently developed approach, called viral RNA interactome capture (vRIC)

Dan Close and Mark Wienhold from 490 Biotech talk in this scientific talk about how to convert endpoint microplate assays to real-time data output.

Erik Schaefer, CEO of AssayQuant Technologies talks about the monitoring of protein kinase and phosphatase activity using kinetic or endpoint formats

Martin Redhead (UCB) discusses the use and impact of kinetic binding methods across the drug discovery pipeline.

In this talk, Support Specialist Joko Logis introduces the BMG LABTECH microplate readers and focuses particularly on protein quantification assays.

Dr Céline Legros explains how you can successfully downscaling screening assays with the PHERAstar.

Dr. Ben Allsop from UCL Drug Discovery Group talks at SLAS 2019 about simulating ischemia-reperfusion injury and how the new CLARIOstar Plus with ACU can help at this research.

In this tutorial Montana Molecular describes a new approach that takes advantage of the dual channel fluorescence detection.

In this scientific talk the speakers talk about cell-based and biochemical high-throughput screening.

This scientific talk covers the recent discovery of a new covalent inhibitor targeting the hitherto undruggable cancer target USP7.

Leave radioactive assays behind: PHERAstar provides temporal resolution to determine kon and koff rates by TR-FRET kinetics

Never again miss the point of a cellular reaction: CLARIOstar measures viability and toxicity in real-time

Learn how the CLARIOstar with ACU replicates in vivo oxygen conditions to increase the significance of your data

Get inspired how to use NanoBRET to monitor G-protein binding, receptor internalization or receptor heteromerization

How the CLARIOstar is used to monitor multiple second messengers in real-time

Tips and tricks to set up and analyze amyloid seeding assays

The speed of the PHERAstar enables kinetic TR-FRET measurements to determine kon and koff rates

Find out why the CLARIOstar’s LVF monochromator is perfectly suited for NanoBRET measurements

Watch how hemoglobin discovers through screening T-VDAcv